18F-fluorodeoxyglucose positron emission tomography predicts lymph node responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma patients | |
Zhu W.; Zhang Y.; Kong L.; Huang Y.; Zheng J.; Wang R.; Li M.; Yu J. | |
刊名 | OncoTargets and Therapy |
2018 | |
卷号 | 11页码:4345-4353 |
关键词 | 18F-FDG-PET/CT Esophageal squamous cell carcinoma Lymph node Personalized radiation dose Radiation dose Radiotherapy Response |
DOI | 10.2147/OTT.S160456 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4583358 |
专题 | 山东大学 |
作者单位 | School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Jinan, Shandong, China, Department of Radiati |
推荐引用方式 GB/T 7714 | Zhu W.,Zhang Y.,Kong L.,et al. 18F-fluorodeoxyglucose positron emission tomography predicts lymph node responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma patients[J]. OncoTargets and Therapy,2018,11:4345-4353. |
APA | Zhu W..,Zhang Y..,Kong L..,Huang Y..,Zheng J..,...&Yu J..(2018).18F-fluorodeoxyglucose positron emission tomography predicts lymph node responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma patients.OncoTargets and Therapy,11,4345-4353. |
MLA | Zhu W.,et al."18F-fluorodeoxyglucose positron emission tomography predicts lymph node responses to definitive chemoradiotherapy in esophageal squamous cell carcinoma patients".OncoTargets and Therapy 11(2018):4345-4353. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论